Biomedical subjects
Publications and source records attributed to R C Haring.
The United States faces increasing cultural diversity in its aging populations. This diversity provides opportunities for home care agencies to expand services as well as to improve patient care. By looking at the demographics, the benefits of comprehensive diversity programs become obvious--for both the agencies themselves and for the clients they serve.
This study examined a personal and professional profile of registered nurses in home care to determine the most influential factors affecting their recruitment, job satisfaction, and retention. With the cooperation of a national, for-profit home healthcare organization in 1990, the authors randomly surveyed its registered nurses, licensed practical nurses, and home health aides in two Midwestern states. Findings for 107 home care registered nurses are presented and compared with responses of licensed practical nurses and home health aides.
How can home health agency managers recruit and retain home care aides effectively? This study reveals the factors that influence aides' work choices, valuable information in battling worker shortage and costly turnover.
Licensed practical nurses are the smallest major segment of the home care industry, providing services with registered nurses and home care aides. Although they report high job satisfaction, LPNs are caught at a middle stage in the health care system. With new demographics, labor market considerations, and recruitment experiences, this report points out the discrepancy between the stalled LPN status and their industry growth.
The bioequivalence of four conjugated estrogens tablets USP was compared by measurement of seven estrogens or estrogen metabolites in the urine during steady-state dosing in postmenopausal women. Two studies compared three generic products with the innovator's product. The urinary excretion of 17 alpha-dihydroequilin, 17 alpha-dihydroequilenin, and 17 alpha-estradiol were significantly greater in all cases with the innovator's product than with the generic products. Statistically significant differences between products were observed occasionally for other components. The generic products thus were bioinequivalent to the innovator's product, although all products essentially met current compendial specifications. A third study observed no significant differences between three batches of the innovator's product for the seven components. Total conjugated estrogens excretion of all products at the steady state was essentially equal and correlated with neither disintegration time nor dissolution half-time. Bioinequivalence between products is discussed in relation to the need for an improved USP conjugated estrogens monograph. Evidence suggesting the metabolism of a fraction of dosed estrone, equilin, and 17 alpha-dihydroequilin to 17 beta-estradiol, 17 beta-dihydorequilim, and 17 alpha-dihydroequilenin, respectively, is presented.
Explore the source record for details and available documents.
Explore the source record for details and available documents.